The WIE Suite’s Post

Healthcare is a business, but also a right 💪🏼 In this article by Cyan (Xiani) Zhong, it’s noted that femtech has seen significant growth recently, yet there are still many topics considered taboo. ✅ Menopause is one of them, despite representing 12% of the population. The article emphasizes that addressing menopause represents not only a commercial opportunity but also a chance to enhance the lives of millions. "Despite the boom, only 5% of femtech startups are building solutions for menopause, a stage of life that 1B+ women will be experiencing by 2025". ⚕️At XOOR, we specialize in the healthcare sector. We build HIPAA compliant apps and are ready to sign Business Associate Agreements (BAA). Feel free to reach out to schedule a meeting. Together, we can brainstorm technological solutions for healthcare! 🩵 https://lnkd.in/ehqH-2Yf #XOOR #Healthcare #Femtech #Startups #Healthtech #HIPAACompliance

#Femtech #Healthcare #Startups #Inclusion #DigitalTransformation 👩🏻 Addressing “taboo” subjects in femtech is essential for inclusive healthcare. Although it impacts on a large population, just 5% of femtech startups focus on menopause. Read Mauricio Payetta’s insight on this topic! 👇🏻

💰 Midi Health, a fast-growing virtual care clinic for women aged 35 and above, has announced the closing of a $63M Series B funding round. Among the new investors is an impressive group of women leaders across various industries, including Amy Schumer, Connie Britton, Brandi Chastain, Meena Harris, Sheryl Sandberg, Tekedra Mawakana, and Tory Burch. This $5M Special Purpose Vehicle (SPV) was formed and managed by Midi Investor Operator Collective and joins a broader group of Series B investors including Emerson Collective, GV (Google Ventures), Memorial Hermann Health System, and others. 🚀 💬 "This is truly an example of women investing in companies such as Midi that they want and believe need to exist in the world, putting their own money behind their belief in our goal of closing the care gap for perimenopause, menopause and beyond. It's exciting to see women of such a wide array of fields and ages at the top of their game coming together to help build solutions in the marketplace that will effect change for other women." Midi Health CEO & Co-founder Joanna Strober #femtech #womenshealth #womenshealthinnovation #femhealth #startup #scaleup #menopause #perimenopause #longevity #investment #investor #vc #venturecapital #femalefounders #healthtech #virtualcare #ecosystem

🌟 Alloy Women's Health, a PACE Healthcare Capital portfolio company, announced today in Fortune (Emma Hinchliffe) that they’ve raised $16 million of capital. We’re beyond proud to have supported the company as investors since 2021 and participated in this funding as the company completes its Series A.   💼 Co-founded by Monica Molenaar and Anne Fulenwider, Alloy is redefining menopause care in a $17 billion global market that has long been overlooked. By prioritizing accessibility, transparency, and evidence-based solutions, they are setting a new standard for advancing women's health in midlife and beyond.   💻 Alloy Health combines telehealth, prescriptions, and a supportive community to address the unique needs of women over 40. For decades, menopause has been treated as a "wellness" topic instead of a medical one, leaving millions of women to suffer in silence. Alloy is changing that by empowering women to find personalized solutions that truly work.   🤝 We’re thrilled to partner with Kairos HQ, Emmeline Ventures, Amboy Street Ventures, and many other incredible investors, to champion Alloy in its next phase of growth. At PACE, we’ve also loved the management team’s disciplined approach to growth, which aligns with our values and defies the traditional laws of venture. Cherry on the cake - here, it isn’t just about investing in a company. It’s about driving a movement to destigmatize menopause and create meaningful health solutions for women.   🎉 Congratulations to the Alloy team! Your work is paving the way for better care, better conversations, and better outcomes for women everywhere. 🚀

We're thrilled to be investing in Midi Health as part of their $60M Series B round! A huge congrats to the Midi team, including Co-Founder and CEO Joanna Strober, Co-Founder and COO Sharon Meers, and Chief Medical Officer Kathleen Jordan, MD, on the incredible work and their announcement! Midi was founded on the belief that *all* women should have access to insurance-covered, expert care for peri/menopause. The company provides specialty care for 36+ common symptoms of perimenopause and menopause including hormonal imbalances and weight management. With this investment, Midi is poised to expand and grow, continuing to close the care gap for women navigating perimenopause, menopause, and related health challenges. A few things we loved about Midi: 📈 Large, Underserved Market: Women in midlife, especially those experiencing perimenopause and menopause, represent a massive and often neglected market. Midi's specific focus addresses a clear need and helps to reduce barriers to care, including drastically reducing wait times for impacted patients. ⚕ Diversified Patient Acquisition Channels: By using direct-to-consumer marketing, employer benefits, and healthcare provider referrals, Midi has created a strong multi-pronged approach to reach women in need of care. 🤝 Defensible Position: Midi is available in all 50 states given strong partnerships with insurance companies and a multi-channel approach for attracting patients, creating a strong position in a competitive healthcare landscape. We're excited to be co-investing alongside Emerson Collective, GV (Google Ventures), Memorial Hermann Health System, SemperVirens Venture Capital , Felicis, Icon Ventures, GingerBread Capital, Able Partners, G9 Ventures and Operator Collective 🔆 We join a syndicate of primarily female-led investors including f7 Ventures, SteelSky Ventures, Muse Capital, Susan Wojcicki, Avestria Ventures and K50 Ventures. https://lnkd.in/eyJqGHmA #WomenInHealth #SeriesB #HealthTechRevolution #menopause #midlifehealth 

THE MENOPAUSE MARKET🩸 Perhaps not something you read everyday on LinkedIn, but for investors and innovators this is the place to be to move the dial on women's health & wellness. $244 million has been invested in the menopause sector of the FemTech industry to date, with exits in the billions. 💸 Read on & download the FemHealth Insights Menopause report to learn more. #menopause #femtech #innovation

🔍 Unveiling Insights in the Menopause Market: A Must-Read for Industry Stakeholders We are excited to announce the publication of our latest comprehensive report on the rapidly expanding menopause market. This meticulously researched document sheds light on the evolving dynamics and significant growth within this niche, spurred by demographic shifts and increasing societal openness. 📊 Key Highlights: -In-depth analysis of 105 companies dedicated to menopause solutions. -Exploration of market trends influenced by demographic changes and legislative support. -Detailed investment insights with a focus on sectors attracting significant capital. -Strategic recommendations for startups, investors, and industry leaders to capitalize on emerging opportunities. 👩💻This report is indispensable for: -Startups seeking to understand their competitive environment and refine their business strategies. -Investors looking to enhance their investment thesis and due diligence processes. -Industry leaders aiming to identify market trends and potential acquisition targets. 🔗 Access the full report and equip yourself with the knowledge to lead and innovate in the women's health sector: https://lnkd.in/eSDa-9AK Stay ahead with FemHealth Insights, where data meets actionable insights to propel you to the forefront of women's health innovation. #Femtech #femhealth #womenshealth #femalehealth #innovation #healthcare #insights #data #research #menopause #aging Brittany Barreto, Ph.D.

MENOPAUSE IS BIG MONEY As a patient advocacy group in Singapore, Menopause Care Alliance is thrilled to see businesses investing in tools that can potentially help women through their perimenopause, menopause and post-menopause journeys. We're definitely here for it. This week, a UK-based startup and app called Flo, that helps women track their periods, raised $200 million from a private equity (PE) firm. Flo says it will use the investment from General Atlantic to increase headcount and expand its offering to cater to women experiencing menopause, according to a Bloomberg story. – Women's health is an "age-old category that has seen historical underinvestment" – Jessie Cai, Principat at General Atlantic. – General Atlantic obviously sees a whole lot of value and ROI investing in Flo –the app reports 68 mln monthly active users and about 5 mln paying subscribers. – Flo isn't the only period tracking app on the market – others like Clue and Ava also help women track their menstrual cycles and sexual activity to monitor health and fertility. These apps fall under the FEMTECH sector that between 2021 and 2023 raised $4.4 billion from venture investors such as private equity and venture capital firms, though not all that money will go into menopause-specific development. #femtech #womenshealth #menopause #healthcare #investment #technology #perimenopause #postmenopause #women

'if it’s wrong for two men to launch a women’s health company solely for profit, the inference is that a period-tracking company founded by women would have a more benevolent motive than merely chasing dollar signs. We expect, even demand, women to have noble reasons for starting companies....Women are required to bare our souls, to tell our story of WHY we do what we do and we do it ad nauseam.' Flo Health Inc. #FloHealth #Perimenopause #Menopause #WomensHealth #mySysters https://lnkd.in/eRHTjxCt